Company Filing History:
Years Active: 2025
Title: Cori A Malinky: Innovator in FGFR Inhibition
Introduction
Cori A Malinky is a notable inventor based in Boulder, CO. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds for FGFR inhibition. His work is essential in advancing treatments for various diseases.
Latest Patents
Cori A Malinky holds 1 patent related to his innovative work. His patent, titled "Compounds for FGFR inhibition," describes a compound with a specific structure, including stereoisomers, salts, or tautomers. The patent also details pharmaceutical compositions comprising these compounds and their applications in treating diseases.
Career Highlights
Cori A Malinky is associated with Cogent Biosciences, Inc., where he continues to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in FGFR inhibition has positioned him as a key player in the field.
Collaborations
Cori has collaborated with notable colleagues, including Jay Bradford Fell and John E Robinson. Their combined efforts enhance the research and development initiatives at Cogent Biosciences, Inc.
Conclusion
Cori A Malinky's work in FGFR inhibition exemplifies the impact of innovative research in pharmaceuticals. His contributions are paving the way for new treatment options and improving patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.